# Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge Augmentations

> **NCT07078331** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Theradaptive, Inc** · enrollment: 45 (actual)

## Conditions studied

- Tooth Extraction Site Healing
- Ridge Augmentation
- Bone Graft

## Interventions

- **DEVICE:** OsteoAdapt DE (0.8 mg)
- **DEVICE:** OsteoAdapt DE (2.0 mg)
- **DEVICE:** Xenograft Bone Graft

## Key facts

- **NCT ID:** NCT07078331
- **Lead sponsor:** Theradaptive, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-17
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07078331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07078331, "Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge Augmentations". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07078331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*